LOC644361 Inhibitors
LOC644361 inhibitors Staurosporine and LY294002 target protein kinases and phosphoinositide 3-kinases respectively, potentially modifying phosphorylation-dependent processes that are essential for LOC644361 function. U0126 and PD98059 are specific to the MAPK/ERK pathway, a pivotal signaling route in cellular proliferation and differentiation, which may exert control over proteins such as LOC644361. Rapamycin and Bortezomib disrupt mTOR signaling and proteasomal degradation, processes that could influence LOC644361 levels or activity. MG132 also targets the ubiquitin-proteasome system, affecting protein turnover and potentially stabilizing proteins that interact with LOC644361.
Other inhibitors, such as Cyclosporin A and NF-κB Inhibitor, modulate immunoregulatory and transcriptional pathways, which could impinge upon the expression and function of LOC644361. Similarly, metabolic inhibitors like 2-Deoxy-D-glucose could affect the energy state of the cell, altering the activity of energy-dependent proteins, which could include LOC644361. Lastly, IWP-2 targets the Wnt signaling, a key pathway in cell fate determination, which might intersect with LOC644361 regulatory mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that can inhibit a wide range of protein kinases, potentially affecting the phosphorylation states required for LOC644361 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A specific inhibitor of PI3K, which can affect downstream signaling pathways that may regulate or interact with LOC644361. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAP kinase inhibitor that can alter stress response pathways that might modulate LOC644361 function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can affect cell growth and proliferation pathways, potentially impacting the regulation of LOC644361. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can increase the levels of proteins regulated by ubiquitination, potentially affecting LOC644361 stability or interaction with other proteins. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressant that can inhibit calcineurin, potentially affecting the dephosphorylation processes important for LOC644361 activity. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can lead to the accumulation of misfolded proteins, potentially affecting LOC644361 if it is part of the proteostasis network. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
A glycolysis inhibitor that can alter energy metabolism, potentially affecting energy-dependent processes of LOC644361. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, which can prevent the activation of MAP kinases, potentially altering signaling pathways involving LOC644361. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
This compound can inhibit NF-κB activation, potentially affecting transcriptional regulation of proteins including LOC644361. | ||||||